Fresenius Medical Care AG
XMUN:FME
Net Margin
Fresenius Medical Care AG
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
26.5B EUR |
3%
|
|
| US |
|
Cigna Corp
NYSE:CI
|
80B USD |
2%
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
67.9B EUR |
2%
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
76.6B USD |
1%
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23.7B EUR |
2%
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.2B USD |
6%
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
18.9B USD |
9%
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
13.2B EUR |
3%
|
|
| US |
|
Hims & Hers Health Inc
NYSE:HIMS
|
12.9B USD |
9%
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
11.2B USD |
7%
|
|
| AU |
|
Sonic Healthcare Ltd
ASX:SHL
|
13.5B AUD |
6%
|
Fresenius Medical Care AG
Glance View
Fresenius Medical Care AG, a titan in the realm of healthcare, traces its origins back to Germany, where its journey began with an unwavering dedication to improving the lives of individuals suffering from chronic kidney failure. This imperative mission is at the core of its operations, merging compassionate patient care with cutting-edge technologies. As the leading provider of dialysis products and services globally, Fresenius Medical Care operates a vast network of renal care facilities, spanning continents, and serves a diverse patient base. The company designs and manufactures a comprehensive range of dialysis machines and related products, which are crucial to the life-sustaining process of cleansing blood when kidneys fail to function effectively. This seamless integration of service provision and product innovation underpins its success, creating a synergy that sets it apart in the healthcare sector. Revenue streams for Fresenius Medical Care are as diverse as they are robust, stemming from both its product line and its extensive network of clinics. The Clinics Division forms the backbone of its business model by offering treatment options directly to patients through a wide network of dialysis centers. Here, it garners revenue by billing healthcare providers and insurance companies for treatments administered. Meanwhile, its Products Division generates income by catering to both its proprietary clinics and third-party healthcare providers with dialysis equipment, consumables, and accompanying services. This dual-faceted structure ensures a steady flow of income, solidifying its position as an indispensable player in the global chronic kidney disease management landscape and making Fresenius Medical Care a stalwart in healthcare delivery systems worldwide.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Fresenius Medical Care AG's most recent financial statements, the company has Net Margin of 3.2%.
You don't have any saved screeners yet